3 European Nations Hit 90% HPV Vaccine Goal

Three European countries just proved that nearly eliminating cervical cancer is possible, not just hopeful thinking.

Iceland, Portugal, and Norway have each reached the 2024 target of vaccinating 90% of girls against HPV by age 15. That's a milestone health officials once thought would take decades to achieve.

The news comes as Europe marks 15 years of HPV vaccination programs across the continent. Today, all European Union countries now recommend the vaccine for both adolescent girls and boys.

The results speak for themselves. Since 2020, every single European country has reported decreased cervical cancer rates among vaccinated women. A Swedish study found that girls vaccinated before age 17 saw an 88% reduction in cervical cancer incidence.

"The elimination of cervical cancer in the EU/EEA is becoming an achievable goal, thanks to the HPV vaccination programmes," said Dr. Bruno Ciancio, who heads the vaccine unit at the European Centre for Disease Prevention and Control. He credits consistent investment in effective immunization strategies for the dramatic progress.

The transformation happened faster than many predicted. Fifteen years ago, HPV vaccination was still new and controversial in some regions. Today, the sustained protection data has convinced skeptics and saved lives.

To help other countries catch up, European health officials launched a new public dashboard this week. It displays real-time vaccination coverage for HPV and other preventable diseases across all European Union nations, creating transparency and healthy competition.

The Ripple Effect

The success of these three countries is already inspiring neighboring nations to boost their own vaccination efforts. When countries share what works, the benefits multiply across borders and save lives far beyond their own populations.

The dashboard gives struggling countries a roadmap to follow, showing exactly which strategies led Iceland, Portugal, and Norway to success. Public health officials across Europe now have concrete proof that ambitious vaccination goals aren't just possible but achievable within years, not generations.

The breakthrough also strengthens the case for HPV vaccination in countries outside Europe still debating whether to invest in national programs.

Cervical cancer elimination in Europe isn't a distant dream anymore, it's a goal within reach.

#